Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL J GOLDSTEIN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1063410645
CMS profile
2193
Location
GREAT NECK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$622.74

34 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $622.74 34

By paying entity

PY2019 · entire year · sorted by reported total

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL J GOLDSTEIN

NPI 1063410645 · CMS profile ID 2193

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

GREAT NECK, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1063410645?year=2019&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL J GOLDSTEIN, NPI 1063410645, CMS profile ID 2193. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1063410645?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MICHAEL J GOLDSTEIN, NPI 1063410645, CMS profile ID 2193. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1063410645?year=2019&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MICHAEL J GOLDSTEIN, NPI 1063410645, CMS profile ID 2193, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–34 of 34 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1063410645?year=2019&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

34 matching records · $622.74 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 34 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–34 of 34.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $14.4012/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681519493 CMS
Merck Sharp & Dohme Corporation $16.6612/11/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695877183 CMS
Merck Sharp & Dohme Corporation $16.4111/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695840905 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.8611/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738533 CMS
Ironwood Pharmaceuticals, Inc $18.9111/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709213297 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.2611/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738531 CMS
Merck Sharp & Dohme Corporation $15.9611/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695872097 CMS
Ironwood Pharmaceuticals, Inc $22.3810/28/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709213299 CMS
Daiichi Sankyo Inc. $24.3210/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695371037 CMS
Merck Sharp & Dohme Corporation $15.6509/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695752769 CMS
PFIZER INC. $21.8809/16/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 673838787 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.0009/09/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738529 CMS
Ferring Pharmaceuticals Inc. $20.6808/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655190025 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.1607/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738527 CMS
Ferring Pharmaceuticals Inc. $16.2506/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655190023 CMS
Merck Sharp & Dohme Corporation $14.0706/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695679447 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.7106/03/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738525 CMS
Merck Sharp & Dohme Corporation $19.7105/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695481359 CMS
Daiichi Sankyo Inc. $17.2305/17/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695323117 CMS
Ferring Pharmaceuticals Inc. $20.9605/13/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655190021 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.6005/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681725955 CMS
Ironwood Pharmaceuticals, Inc $16.6304/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709213301 CMS
Merck Sharp & Dohme Corporation $19.1804/15/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695446827 CMS
Gilead Sciences, Inc. $13.1304/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 681519491 CMS
Ironwood Pharmaceuticals, Inc $15.5703/05/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709213303 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $0.8602/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738521 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.5002/27/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 684738523 CMS
Janssen Biotech, Inc. $22.1402/22/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 658449965 CMS
Ferring Pharmaceuticals Inc. $16.7102/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655190019 CMS
Daiichi Sankyo Inc. $24.6802/01/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 695301259 CMS
PFIZER INC. $16.8201/30/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671895557 CMS
Ironwood Pharmaceuticals, Inc $19.2101/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 709213305 CMS
PFIZER INC. $19.8001/23/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 671849153 CMS
Ferring Pharmaceuticals Inc. $22.4501/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655190017 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $622.74 34
PY2020 $554.05 32
PY2021 $303.05 16
PY2022 $155.50 9
PY2023 $187.37 4
PY2025 $267.73 2

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $88,071.47 22
PY2023 Principal investigator $169,779.57 14
PY2022 Principal investigator $32,010.78 12
PY2021 Recipient $3,971.40 2
PY2021 Principal investigator $162,998.92 79
PY2020 Principal investigator $489,931.11 140
PY2019 Recipient $883.66 5
PY2019 Principal investigator $583,175.74 159

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

12 records in PY2022

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,108.40 12/20/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL
CONTINUATION STUDY WITH BUDESONIDE ORAL SUSPENSION (BOS) FOR ADOLESCENT AND ADULT SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 937180613
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $786.83 12/15/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938712591
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,175.00 12/08/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938711565
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $175.00 06/28/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938650577
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $175.00 05/26/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938634233
Principal investigator 1 Celgene Corporation $16,487.00 04/04/2022 Non-covered Recipient Entity
Long Island Gastrointestinal Research Group
A Multi-Center, Multi-National, Randomized, Double - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Subjects wit No dispute reported 06/30/2026 937184611
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $841.72 03/24/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938619369
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $175.00 02/24/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938616713
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $2,818.17 02/17/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938615719
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $78.60 02/17/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938615721
Principal investigator 1 Regeneron Pharmaceuticals, Inc. $1,564.86 01/27/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RSRCH GRP LLP
A PHASE 3, RANDOMIZED, 3-PART STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF DUPILUMAB IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS (EOE) No dispute reported 06/30/2026 938614377
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $6,625.20 01/25/2022 Non-covered Recipient Entity
LONG ISLAND GASTROINTESTINAL RESEARCH GROUP LLP
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, PHASE 2B STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TWICE-DAILY ORAL ADMINISTRATION OF A PERIPHERALLY ACTING DOPAMINE RECEPTOR D2/D3 ANTAGONIST, TAK-906 FOR THE TREATMENT OF ADULT SUBJECTS WITH SYMPTOMATIC IDIOPATHIC OR DIABETIC GASTROPARESIS No dispute reported 06/30/2026 937162305